-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Qilu Pharmaceutical's application for consistency evaluation of clozapine tablets was approved by the National Medical Products Administration
Clozapine tablets are dibenzodiazepine antipsychotics, which exert a powerful sedative and hypnotic effect by directly inhibiting the ascending activation system of the brainstem network structure, and are clinically used for the treatment of refractory schizophrenia
In 2018, Qilu Pharmaceutical started the consistency evaluation of clozapine tablets
In addition, Qilu Pharmaceutical's supplementary application for the consistency evaluation of the new specification of nedaplatin for injection (Lube®) was also approved recently, and it is mainly used clinically for head and neck cancer, small cell lung cancer, non-small cell lung cancer, and esophageal cancer.
Over the years, Qilu Pharmaceutical has adhered to the original intention and mission of "holding the Chinese medicine bottle tightly in its own hands", actively responded to the national centralized procurement policy, and achieved remarkable results